During the past decade, Hospital Son Llàtzer conducted 135 clinical trials. In the 10-year time frame, 135 clinical trials started and 47 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 25 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Son Llàtzer" #1 sponsor was "PETHEMA Foundation" with 30 trials, followed by "Hoffmann-La Roche" with 14 trials sponsored, "Celgene" with 11 trials sponsored, "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 8 trials sponsored and "Pfizer" with 8 trials sponsored. Other sponsors include 151 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Son Llàtzer" #1 collaborator was "AstraZeneca" with 5 trials as a collaborator, "Breast International Group" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Celgene" with 4 trials as a collaborator and "Novartis" with 4 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 114 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Son Llàtzer" are "Multiple Myeloma" (15 trials), "Breast Cancer" (12 trials), "Acute Lymphoblastic Leukemia" (7 trials), "Lung Cancer" (7 trials) and "Ovarian Cancer" (6 trials). Many other conditions were trialed in "Hospital Son Llàtzer" in a lesser frequency.

Most popular intervention types in "Hospital Son Llàtzer" are "Drug" (168 trials), "Other" (20 trials), "Procedure" (12 trials), "Biological" (8 trials) and "Device" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Dexamethasone" (14 trials), "Carboplatin" (13 trials), "Paclitaxel" (11 trials) and "Cisplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Son Llàtzer" are 184 trials for "All" genders, 40 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 84 active trials in "Hospital Son Llàtzer". 3 are not yet recruiting, 45 are recruiting, 34 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 110 completed trials in Hospital Son Llàtzer, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Son Llàtzer, 6 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 15 trials that are defined as “Not Applicable".